Do we need to treat chronic active T cell-mediated rejection?

Area of Science:

• Nephrology
• Transplant Immunology
• Pathology

Background:

• Chronic active T cell-mediated rejection (CA TCMR) is a significant cause of long-term kidney allograft failure.
• Inflammation within fibrotic areas characterizes CA TCMR, highlighting a complex interplay of injury and repair processes.

Purpose of the Study:

• To describe a series of chronic active T cell-mediated rejection (CA TCMR) cases.
• To analyze the clinical, molecular, and pathologic features of CA TCMR.
• To evaluate the response to therapy in patients with CA TCMR.

Main Methods:

• Case series analysis
• Clinical data review
• Molecular profiling
• Pathologic examination

Main Results:

• Detailed characterization of the diverse clinical, molecular, and pathologic phenotypes of CA TCMR.
• Insights into the heterogeneity of this rejection type.
• Assessment of treatment responses across different CA TCMR presentations.

Conclusions:

• Understanding the diverse features of CA TCMR is crucial for effective patient management.
• This translational study provides a foundation for developing targeted therapies.
• Further research is needed to optimize treatment strategies for CA TCMR to improve long-term allograft survival.